Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients

Metabolism: Clinical and Experimental

Volumn 55, Issue 2, 2006, Pages 258-262

  Taniguchi, Ataru ^a   Fukushima, Mitsuo ^b   Ohya, Michihiro ^a   Nakai, Yoshikatsu ^c   Yoshii, Satoru ^a   Nagasaka, Shoichiro ^d   Matsumoto, Kazunari ^e   Taki, Yoshiro ^a   Kuroe, Akira ^a   Nishimura, Fusanori ^f   Seino, Yutaka ^a  

^a KANSAI DENRYOKU HOSPITAL   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e Diabetes Center   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN RESISTANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADIPONECTIN; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; JAPAN; LEPTIN; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 30744477042     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.08.020     Document Type: Article

References (33)

1. J.E. Gerich The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity (Review) Endocr Rev 19 1998 491 503
2. A. Taniguchi, M. Fukushima, M. Sakai, K. Kataoka, I. Nagata, and K. Doi The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients Metabolism 49 2000 1001 1005
3. A. Taniguchi, M. Fukushima, M. Sakai, K. Miwa, T. Makita, and I. Nagata Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients Diabetes Care 23 2000 1766 1769
4. T. Okumura, A. Taniguchi, S. Nagasaka, M. Sakai, M. Fukushima, and A. Kuroe Relationship of regional adiposity to serum leptin level in nonobese Japanese type 2 diabetic male patients Diabetes Metab 29 2003 15 18
5. T. Yatagai, S. Nagasaka, M. Fukushima, A. Taniguchi, T. Nakamura, and A. Kuroe Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in subjects with type 2 diabetes mellitus Metabolism 52 2003 1274 1278
6. A. Taniguchi, Y. Nakai, M. Sakai, S. Yoshii, D. Hamanaka, and Y. Hatae Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients Metabolism 51 2002 544 548
7. V. Mohamed-Ali, S. Goodrick, A. Rawesh, D.R. Katz, J.M. Miles, and J.S. Yudkin Subcutaneous adipose tissue releases interleukin 6, but not tumor necrosis factor-α, in vivo J Clin Endocrinol Metab 82 1997 4196 4200
8. A.L. Carley, and M.A. Febbraio Interleukin-6 and insulin sensitivity: friend or foe? Diabetologia 47 2004 1135 1142
9. J.P. Bastard, C. Jardel, E. Bruckert, P. Blondy, J. Capeau, and M. Laville Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss J Clin Endocrinol Metab 85 2000 3338 3342
10. S.M. Haffner, A.S. Greenberg, W.M. Weston, H. Chen, K. Williams, and M.I. Freed Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus Circulation 106 2002 679 684
11. A. Taniguchi, Y. Nakai, M. Fukushima, H. Kawamura, H. Imura, and I. Nagata Pathogenic factors responsible for glucose tolerance in patients with NIDDM Diabetes 41 1992 1540 1546
12. S. Nagasaka, K. Tokuyama, I. Kusaka, H. Hayashi, K. Rokkaku, and T. Nakamura Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach Diabetes 48 1999 1054 1060
13. World Health Organization Diabetes mellitus: report of a WHO Study Group 1985 World Health Org Geneva [Tech. Rep. Ser., no. 727]
14. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
15. E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, and G. Targher Prevalence of insulin resistance in metabolic disorders: the Bruneck Study Diabetes 47 1998 1643 1649
16. L.C. Groop Drug treatment of non-insulin-dependent diabetes mellitus J. Pickup G. Williams Textbook of diabetes vol. 8 1997 Blackwell Oxford (UK) 1 18
17. E. Bonora, G. Targher, M. Alberiche, R.C. Bonadonna, F. Saggiani, and M. Zenere Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity Diabetes Care 23 2000 57 63
18. M. Emoto, Y. Nishizawa, K. Maekawa, Y. Hiura, H. Kanda, and T. Kawagichi Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas Diabetes Care 22 1999 818 822
19. A. Taniguchi, Y. Nakai, K. Doi, H. Fukuzawa, M. Fukukshima, and H. Kawamura Insulin sensitivity, insulin secretion, and glucose effectiveness in obese subjects: a minimal model analysis Metabolism 44 1995 1397 1400
20. S.M. Haffner, R. D'Agostino Jr, L. Mykkanen, R. Tracy, B. Howard, and M. Rewers Insulin sensitivity in subjects with type 2 diabetes: relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study Diabetes Care 22 1999 562 568
21. R.L. Chaiken, M.A. Banerji, R.M. Pasmantier, H. Huey, S. Hirsch, and H.E. Lebovitz Patterns of glucose and lipid abnormalities in black NIDDM subject Diabetes Care 14 1991 1036 1042
22. M. Fukushima, M. Usami, M. Ikeda, Y. Nakai, A. Taniguchi, and H. Suzuki Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes Metabolism 53 2004 831 835
23. N. Abate, A. Garg, R.M. Peshock, J. Stray-Gunderson, B. Adams-Huet, and S.M. Grundy Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM Diabetes 45 1996 1684 1693
24. M.A. Banerji, R.L. Chaiken, D. Gordon, J.G. Kral, and H.E. Lebovitz Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes 44 1995 141 146
25. P.A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab 280 2001 E745 E751
26. B. Vozarova, C. Weyer, K. Hanson, P.A. Tataranni, C. Bogardus, and R.E. Pratley Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion Obes Res 9 2001 414 417
27. A.L. Carey, C.R. Bruce, M. Sacchetti, M.J. Anderson, D.B. Olsen, and B. Saltin Interleukin-6 and tumor necrosis factor-α are not increased in patients with type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness Diabetologia 47 2004 1029 1037
28. S.M. Haffner, A.S. Greenberg, W.M. Weston, H. Chen, K. Williams, and M.I. Freed Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus Circulation 106 2002 679 684
29. A. Steensberg, C.P. Fischer, and M. Sacchetti Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans J Physiol 548 2003 631 638
30. A. Taniguchi, Y. Nakai, K. Tokuyama, M. Sakai, K. Doi, and M. Fukushima Role of glucose effectiveness in the evolution of NIDDM R.N. Berman J.C. Lovejoy The minimal model approach and determinants of glucose tolerance vol. 7 1997 Louisiana State University Press 357 367
31. D. Lyngs, L. Simonsen, and J. Bulow Interleukin-6 production in human subcutaneous abdominal adipose tissue: effect of exercise J Physiol (Lond) 543 2002 1033 1046
32. J.M. Fernandez-Real, M. Broch, J. Vendrell, C. Gutierrez, R. Casamitjana, and M. Pugeat Interleukin-6 gene polymorphism and insulin sensitivity Diabetes 49 2000 517 520
33. M. Ohya, A. Taniguchi, M. Fukushima, Y. Nakai, Y. Kawasaki, and S. Nagasaka Three measures of tumor necrosis factor-alpha activity and insulin resistance in non-obese Japanese type 2 diabetic patients Metabolism 54 2005 1279 1301